Stock Watch: Global Issues Sway Big Pharma Stocks In Q4 Earnings Season

But Some Of Pfizer’s Challenges Were Of Its Own Making

Taking a broad view of big pharma share price movements as the sector reported 2024 financials, company-specific issues were complicated by geopolitical factors including Donald Trump’s tariff announcements.

Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from Stock Watch

More from Earnings